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Evidence for nonoperative management of acute
limb ischemia in infants
Jesus M. Matos, MD,a Andres Fajardo, MD,a Michael C. Dalsing, MD,a Raghu Motaganahalli, MD,a
George A. Akingba, MD, PhD,a and Michael P. Murphy, MD,a,b Indianapolis, Ind
Acute limb ischemia (ALI) in infants is a catastrophic event. We performed a query of our database to determine those
with ALI. Twelve patients were identified. The most frequent presentation was cyanotic limbs. Eleven patients were
treated nonoperatively with anticoagulation. One patient was treated surgically with Fogarty balloon thrombectomy.
There were three deaths all due to associated comorbidities. All had viable limbs on follow-up examination. There were
three complications in the patients managed conservatively. Our recommendation for infants presenting with ALI is
conservative observation with anticoagulation and intervention only for cases with tissue loss. ( J Vasc Surg 2012;55:
1156-9.)
R
w
m
a
p
e
c
o
fi
a
d
i
s
(
t
V
j
c
a
a
r
p
(
a
u
k
(
s
t
e
f
w
h
c
b
rAcute limb ischemia (ALI) is a catastrophic event that
portends a significant probability of limb loss. ALI in the
infant population (1 year old) is an exceedingly rare
clinical event, and consequently, consensus management
guidelines do not exist.1-2 Over the past decade, there have
been several successful reports of limb salvage in children
over a wide range of ages with anticoagulation and/or
thrombolytic therapy but no series focusing specifically on
the infant population with ALI.3-6 In this report, we pro-
vide a review of our experience in the management of ALI
in the infant population, demonstrating efficacy in limb
salvage with conservative management consisting of anti-
coagulation and close monitoring of limb viability.
METHODS
The Indiana University School of Medicine Vascular
Surgery Section maintains a database of all vascular inter-
ventions and consultations performed by our staff at the
Clarian Hospital System (Methodist, University, and Ri-
ley). The protocol of this study was approved by institu-
tional review board review. Query of this database for all
patients with acute limb ischemia in infants (defined as less
than 1 year of age) from 2004 to 2010was conducted. Data
collected and analyzed included age, gender, medical co-
morbidities, affected extremity, mechanism of occlusion,
presenting symptoms, diagnostic studies, treatment, and
follow-up data.
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1156ESULTS
Between November 21, 2004 and April 12, 2010 there
ere 12 patients identified with ALI7 (Fig 1). Injuries were
ore common in male patients (n  9; 75%) with an
verage age of 3 months (range, 10 days-8 months). At
resentation, seven (59%) patients had absent pulses by
xamination, and nine (75%) had limb cyanosis (Fig 2). A
olor-flow duplex ultrasound (DUS) was initially obtained
n all patients that provided sufficient information to con-
rm the diagnosis, mitigating the need for additional im-
ging studies. Comorbidities included congenital cardiac
isease (n 5; 42%), pulmonary failure requiring mechan-
cal ventilation (n  4; 33%), prematurity (n  1; 8%),
epsis (n  1; 8%), and intermittent methemoglobinemia
n  1; 8%).
Intra-arterial catheterizations for diagnostic or moni-
oring purposes were the cause of ALI in 11 (92%) patients.
essels of the lower extremity were more commonly in-
ured (n  9; 75%), and arteries that were injured were the
ommon femoral artery (n  7; 58%), superficial femoral
rtery (n 2; 17%), radial artery (n 2; 17%), and brachial
rtery (n  1; 8%). Six of the patients had dopamine
unning during evaluation of the ischemic event. Twelve
atients were anticoagulated with unfractionated heparin
n  10) or subcutaneous (SQ) enoxaparin.2 Unfraction-
ted heparin was administered as an initial bolus of 100
nits/kg followed by continuous infusion of 20 units/
g/hr to achieve an activated partial thromboplastin time
APTT) of 2 to 2.5 times normal. DUS was performed
erially during the critical period of initiating anticoagula-
ion. All patients were transitioned from heparin to SQ
noxaparin. Patients continued for 3 to 4 weeks with
ollow-up DUS. There was one failure of anticoagulation
ith heparin manifesting as ulceration and gangrene 48
ours after initiation of therapy. The patient underwent
ommon femoral artery thrombectomy with a #3 Fogarty
alloon catheter and four compartment fasciotomies with
estoration of distal pulses.
There were two deaths (18%) in the anticoagulation
roup during treatment for ALI. One patient died 2 days
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Volume 55, Number 4 Matos et al 1157and the second patient died 9 days after vascular surgery
evaluation due to heart failure. Out of the remaining nine
patients, we had follow-up data on seven. On follow-up
visits, every patient had repeat DUS. Three patients expe-
rienced complications felt to be related to limb ischemia:
One was found to have a size discrepancy of 1 cm of the
foot on the fully functional index limb, a second patient
required skin debridement and grafting due to skin necro-
sis, and the third patient lost a fingernail. One patient had a
follow-up DUS 24 days after treatment with enoxaparin
that documented persistent occlusion of the common fem-
oral artery with notable development of a collateral branch
perfusing the superficial femoral artery (Fig 3). The one
patient that was managed with surgical thrombectomy died
30 days after surgery from septic shock unrelated to the
surgery or complications of limb ischemia.
DISCUSSION
Infant vascular injuries are rare and account for1% of
patients with acute limb ischemia seen by vascular sur-
geons.8 Iatrogenic vascular injuries are more common in
Fig 1. Arterial duplex ultrasound of 6-month-old infant at time
of presentation. Duplex demonstrates a relative absence of flow in
the common femoral artery with monophasic waveforms and sig-
nificantly reduced velocities.
Fig 2. Infant with cyanotic limb at time of presentation.the infant population, while older children and adolescent iill experience penetrating injuries.9-11 Common causes
or infant vascular injuries are cardiac catheterizations and
rterial blood pressure monitoring devices.11 “Soft signs”
f vascular injury are difficult to evaluate on this population
ge due to lack of verbalization of pain and diminished or
bsent sensation.8 In the infant population, active bleeding
s the absolute indication for operation.12
There is limited literature when it comes to manage-
ent of infants with ALI. Surgical management of these
njuries represents a technical challenge; not only the small
essel size but also the problem of arterial spasms can cause
ifficulties. Our institution previously published how open
urgical repair in older children with blunt vascular injuries
llowed limb salvage in the absence of diagnostic delay.12
here are multiple series that report surgical intervention of
ediatric patients1,12-15 and infants2,16,17 with ALI, but
ccording to Lin et al15 operative results in children
ounger than 2 years leads to less satisfactory outcomes
hen compared with older children.5,9 Lazarides et al
onducted a review of the literature describing outcomes of
urgically managed patients in children 2.5 years of age
nd found only 48% of patients were able to regain palpable
ulses, and limb discrepancy was detected in asmany as 15%
f patients.3
In terms of a more conservative approach, there are
everal management guidelines that have been pro-
osed.2,3,18,19 One includes the use of thrombolytic agents
s the first-choice therapy for 48 hours followed by micro-
urgery if no improvement was seen.2 Lazarides et al rec-
mmended only operating on infants with definite threat of
imb loss and doing systemic heparinization or thrombo-
ytic therapy, knowing that limb length discrepancies will
e inevitable.3 The recommended conservative method is
he administration of heparin as an initial bolus of 75 to 100
nits/kilogram with an infusion depending on age: for
he 2 month old, 28 units/kilogram/hour, while older
ig 3. Arterial duplex ultrasound of a month-old infant 24 days
fter treatment with anticoagulation, showing occlusion with lack
f flow. Blue represents collateral flow formation with green arrow
epresenting refeeding distal flow.nfants require only 20 units/kilogram/hour.8,20 Other
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April 20121158 Matos et algroups recommend the use of thrombolytic agents in a
selective group of patients who do not respond to systemic
heparin anticoagulation.19,20 Criticism of conservative
management includes the possibility of developing com-
partment syndrome and limb length discrepancies.3,9,11
In the infant population, supportive care and the use of
systemic anticoagulation with heparin is the best manage-
ment for most patients. Limb viability was 100% in this
series of infants with ALI managed nonoperatively, and we
propose that favorable remodeling in parallel collateral
vessels occurs due to changes in flow dynamics with acute
occlusion. Our recommendation for infants presenting
with ALI is physical examination followed by DUS and
systemic anticoagulation with heparin and transitioned to
SQ lovenox. Patients should undergo serial examinations
to assess changes in perfusion of the index limb and a repeat
DUS in 3 to 4 weeks. We further recommend that if
adequate perfusion of the limb is established by examina-
tion and DUS, then anticoagulation should be stopped.
During the observational period, it is important for the
vascular surgeon to establish expectations with the family.
It is important to warn the family that the child could suffer
limb discrepancies. If DUS depicts restoration of flow with
collateral formation, anticoagulation can be stopped. Sur-
gical intervention is indicated in patients with tissue loss,
active bleeding, or lack of response to systemic anticoagu-
lation.
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Dr George Hamilton (London, United Kingdom). Congrat-
ulations on your results; we have a similar experience. What you
haven’t mentioned is thrombolysis. As a tertiary referral center, a
lot of our children get to us late, having been treated at other
hospitals. Our protocol is to start with anticoagulation absolutely
monitored with APTT for a period of 6 hours or so. If that doesn’t
improve perfusion, systemic thrombolysis is then used. There is a
risk, particularly in preterm infants, of cerebral hemorrhage, but
that risk actually is worth taking because the results of thrombolysis
are universally good except in irreversible ischemia. We would
agree absolutely that there is really a very little role for surgical
intervention because the results are dreadful.
Dr Jesus Matos. The one patient that underwent thrombec-
tomy was transferred from an outside institution, and by the time
he got to our institution, it was too late to consider thrombolysis.n adequate option. Unfortunately, in our series we don’t have any
ids that underwent thrombolysis treatment.
Dr Jonathan Beard (Sheffield, United Kingdom): I’d like to
oncur with not operating on these babies. My experience with
wo have been disastrous. It’s like operating on a piece of wet tissue
aper.
I’m a bit worried about your suggestion that you should wait.
ou seem to suggest that it is best to wait until the limb is going
lack before you intervene. Have you thought about other meth-
ds of monitoring limb perfusion, maybe compartment pressures,
or instance, to see if the compartment pressure is going up? That
ight be an indication for the need for intervention.
Dr Matos. We did not measure compartment pressures on
ny of our patients. We feel that very close monitoring of these kids
y the vascular team several times a day is sufficient.Dr Beard. What features on physical examination do you use
o determine intervention?
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Volume 55, Number 4 Matos et al 1159Dr Matos. Rutherford Class 3 with gangrene and extensive
tissue loss. I agree, it’s difficult, because you don’t have the ability
to check whether the kid has sensation, whether they’re able to
move on command, so it is a little more challenging in that sense.
Dr William Turnipseed (Madison, Wisc). I have some anec-
dotal experience that really predates the more current thrombo-
lytic and antiplatelet medications. I have three patients that I’ve
actually followed for almost 20 years. One of my questions will be:
Do you have any examples of pediatric infant injuries that predate
your study to give you longer follow-up? Because the real critical
issue is not what happens in the first 3 months, but for the
survivors, information relative to their lifestyle and any morbidity
down the road.
I can tell you that from my experience, I had three cases that
extended over about a 6-year period. They were all very similar.
They were all cardiac cases. In each case, a cardiac catheter had
knotted in the common iliac, and the external iliac was totally
evulsed and pulled out through the groin. This really taught me a
lesson, and that is, that if the hypogastric is open and the profunda
is open, that anticoagulation actually stands a very good chance of
working on these patients.
The long-term follow-up has been very interesting. I would
have suspected some limb deformity. Your point about generous
collateral development in the very young is quite accurate in that all
three of these have grown up with normal leg length and normal
leg function, after 2 decades of follow-up.
Dr Matos. Thank you for your comments. Actually, Dr
Dalsing knows, by name, every single patient in this study because
he’s been following them very extensively. Unfortunately, it’s
difficult for us to follow some of these kids long-term because we
are the only tertiary center in the state of Indiana, and a lot of these
kids come from out of town. And a lot of time, the follow-up is
i
tased on what the primary care surgeon tells us over the phone.
ut from what we can tell, Dr Dalsing has been following the
ongest kid for about 6 years now with no limb discrepancies.
Dr Timothy Baxter (Omaha, Neb). My question is about
asciotomies. I’ve had a hard time making that decision in some of
hese kids. I’ve watched their CPK levels because the physical
xamination may be hard to interpret. In seeing them back in
ollow-up, I have seen some gait abnormalities. So the question is,
ow do you decide about whether to perform a fasciotomy?
Dr Matos. The one kid that we performed the open throm-
ectomy with the fasciotomy had very severe tissue loss with
angrene and had been mismanaged by the outside institution for
ver 12 hours, so the decision for us to perform the fasciotomy was
retty straightforward. But it is difficult to come to that decision, I
gree.
Dr Malachi Sheahan (New Orleans, La). Since what you’re
escribing is the treatment of iatrogenic injuries to the common
emoral artery rather than congenital anomalies, I think it would be
seful if you expanded the group to include children up to 4 or 5
ears of age. Dr Lumsden has one of the largest reported series in
hich he manages these children fairly aggressively, a lot of them
ith bypass. Overall, however, the literature suffers from a lack of
umbers. So if you have more cases to add to the worldwide
xperience, I’d be interested to see what happens with these kids
p to 2, 3, 4 years old, especially with regard to limb length and
unctional development.
DrMatos. I agree. Most of the literature out there, including
r Lumsden’s and Dr Lin’s publication, is from kids 2 years of
ge that were managed surgically. There is a greater correlation of
imb length discrepancy in that age group, but there is not as much
n kids younger than 2, which is why we were interested in studying
his age group.
